Computational design of dynamic biosensors for emerging synthetic opioids

Nitazenes are an emergent class of synthetic opioids that often rival or exceed fentanyl in their potency. These compounds have been detected internationally in illicit drugs and are the cause of increasing numbers of hospitalizations and overdoses. New analogs are consistently released, making detection challenging - new ways of testing a wide range of nitazenes and their metabolic products are urgently needed. Here, we develop a computational protocol to redesign the plant abscisic acid receptor PYR1 to bind diverse nitazenes and maintain its dynamic transduction mechanism. The best design has a low nanomolar limit of detection in vitro against nitazene and menitazene. Deep mutational scanning yielded sensors able to recognize a range of clinically relevant nitazenes and the common metabolic byproduct in a complex biological matrix with limited cross-specificity against unrelated opioids. Application of protein design tools on privileged receptors like PYR1 may yield general sensors for a wide range of applications in vitro and in vivo.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2026-01-07
DOI
https://doi.org/10.1038/s41467-025-67994-w
Primary Topic
Polyamine Metabolism and Applications
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Computational design of dynamic biosensors for emerging synthetic opioids

Sean R. Cutler, Samuel D. Swift, Zachary T. Baumer, Ian Wheeldon et al.
Nature Communications
Polyamine Metabolism and Applications
article

Computational design of dynamic biosensors for emerging synthetic opioids

Sean R. Cutler, Samuel D. Swift, Zachary T. Baumer, Ian Wheeldon, Anika J. Friedman, Alison C. Leonard, Timothy A. Whitehead, Michael R. Shirts, Rachel Chayer, Chase Lenert-Mondou, Lindsey M. Whitmore, Norman Seder, Jordan Wells, Ryan Delaney, Nicholas R. Robertson
article en

Abstract

Nitazenes are an emergent class of synthetic opioids that often rival or exceed fentanyl in their potency. These compounds have been detected internationally in illicit drugs and are the cause of increasing numbers of hospitalizations and overdoses. New analogs are consistently released, making detection challenging - new ways of testing a wide range of nitazenes and their metabolic products are urgently needed. Here, we develop a computational protocol to redesign the plant abscisic acid receptor PYR1 to bind diverse nitazenes and maintain its dynamic transduction mechanism. The best design has a low nanomolar limit of detection in vitro against nitazene and menitazene. Deep mutational scanning yielded sensors able to recognize a range of clinically relevant nitazenes and the common metabolic byproduct in a complex biological matrix with limited cross-specificity against unrelated opioids. Application of protein design tools on privileged receptors like PYR1 may yield general sensors for a wide range of applications in vitro and in vivo.

Nature CommunicationsVol. 17(1)
University of California, Riverside (US), University of Colorado Boulder (US)
National Science Foundation, U.S. Department of Energy, National Institutes of Health, Defense Advanced Research Projects Agency, University of Colorado Boulder
Good health and well-being
Openalex Percentile: Top 95%
Polyamine Metabolism and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.